Psoriasis - An Evidence Based Update
Thursday 22nd May 2004 - Novotel, Nottingham
Click here to download programme in Word format
PROGRAMME
| 09.00am | Arrival and coffee | ||
| Title | Presenter | ||
| 10.00am (20 mins + 10 mins discussion) |
Randomised Controlled Trial 1 | Randomised Controlled Trial 1 Methotrexate vs cyclosporine in moderate-to-severe chronic plaque psoriasis | Menno de Rie Amsterdam |
| 10.30am (20 mins + 10 mins discussion) |
Systematic Review 1 | Cochrane Review of Treatments For Scalp Psoriasis | Jason Willams Manchester |
| 11.00am (20 mins + 10 mins discussion) |
Randomised Controlled Trial 2 | Randomised Controlled Trial 2 Oral Pimecrolimus: Development of a systemic agent for moderate to severe psoriasis. | Carle Paul Novartis, Basel |
| 11.30am | Coffee | ||
| 12.00pm | Panel discussion to questions from the Psoriasis Association, hosted by Hywel Williams | Addressed to the ‘Three Wise Men’: Jonathan Barker, Chris Griffiths, Menno de Rie | |
| 1.00pm | Lunch | ||
| 2.00pm (20 mins + 10 mins discussion) |
Randomised Controlled Trial 3 | 1% Prepared Coal Tar vs 5% Coal Tar | Stephen Kownacki Northampton |
| 2.30pm (20 mins + 10 mins discussion) |
Systematic Review 2 | Topical treatments for psoriasis in primary care: a review update | James Mason Newcastle upon Tyne |
| 3.00pm (20 mins + 10 mins discussion) |
Clinical Overview | Biologicals vs pharmaceuticals: the future of therapy for severe psoriasis | Chris Griffiths Manchester |
| 3.30pm | Summing up | Hywel Williams Nottingham | |
| 4.00pm | Meeting close | ||
